Home › Funds › WestHill Financial Advisors, Inc. › NRIX

WestHill Financial Advisors, Inc. position in NRIX

NURIX THERAPEUTICS INC · Health Care

WestHill Financial Advisors, Inc. reported holding 208,333 shares of NRIX (NURIX THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$4.9M, representing 0.83% of its reported portfolio and ranking #17 among its reported holdings. WestHill Financial Advisors, Inc. has disclosed NRIX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)208.33K sh
Reported value held$4.94M
Portfolio Weight0.83%
First reportedQ3 2023
Last changeReduce
Updated2026-10-14

Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR

How WestHill Financial Advisors, Inc.'s NRIX position evolved

WestHill Financial Advisors, Inc. first disclosed a stake in NRIX in Q3 2023 at 283,333 shares (US$2.2M). The position peaked in Q2 2024 at 283,333 shares, worth US$5.9M. Across 13 filings, WestHill Financial Advisors, Inc. increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 208,333 shares valued at US$4.9M — a reduction of -10,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 283.33K $2.23M New
Q4 2023 283.33K $2.92M Hold
Q1 2024 283.33K $4.16M Hold
Q2 2024 283.33K $5.91M Hold
Q3 2024 238.33K $5.36M Reduce
Q4 2024 228.33K $4.30M Reduce
Q1 2025 228.33K $2.71M Hold
Q2 2025 228.33K $2.60M Hold
Q3 2025 228.33K $2.11M Hold
Q4 2025 228.33K $4.33M Hold
Q1 2026 228.33K $3.54M Hold
Q2 2026 218.33K $5.30M Reduce
Q3 2026 208.33K $4.94M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NRIX and 13F data

NRIX (NURIX THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in NRIX — the largest reported positions include Vestal Point Capital, LP (US$195.3M), Deep Track Capital, LP (US$187.7M), Rubric Capital Management LP (US$175.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NRIX

All NRIX fund holders →

FAQ

How long has WestHill Financial Advisors, Inc. held NRIX?

WestHill Financial Advisors, Inc. has disclosed NRIX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is WestHill Financial Advisors, Inc.'s current position in NRIX?

As of Q3 2026, WestHill Financial Advisors, Inc. holds 208.33K shares of NRIX (NURIX THERAPEUTICS INC), valued at $4.94M, representing 0.83% of its reported portfolio and ranking #17.

Has WestHill Financial Advisors, Inc. been buying or selling NRIX?

In the latest 13F filing (Q3 2026), WestHill Financial Advisors, Inc. reduced its position in NRIX. The position peaked in Q2 2024 at 283.33K shares.

Which other funds hold NRIX?

Other major institutional holders of NRIX include Vestal Point Capital, LP, Deep Track Capital, LP, Rubric Capital Management LP, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.